Furthermore, ADSCs can reduce the proliferation of HSCs by downregulating IL-17 expression and further inhibiting the progression of hepatic fibrosis in NASH mice [16]. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.